Correlation Between Peoples Insurance and Chengdu Kanghua

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Peoples Insurance and Chengdu Kanghua at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Peoples Insurance and Chengdu Kanghua into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Peoples Insurance of and Chengdu Kanghua Biological, you can compare the effects of market volatilities on Peoples Insurance and Chengdu Kanghua and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Peoples Insurance with a short position of Chengdu Kanghua. Check out your portfolio center. Please also check ongoing floating volatility patterns of Peoples Insurance and Chengdu Kanghua.

Diversification Opportunities for Peoples Insurance and Chengdu Kanghua

0.89
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Peoples and Chengdu is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Peoples Insurance of and Chengdu Kanghua Biological in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chengdu Kanghua Biol and Peoples Insurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Peoples Insurance of are associated (or correlated) with Chengdu Kanghua. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chengdu Kanghua Biol has no effect on the direction of Peoples Insurance i.e., Peoples Insurance and Chengdu Kanghua go up and down completely randomly.

Pair Corralation between Peoples Insurance and Chengdu Kanghua

Assuming the 90 days trading horizon Peoples Insurance is expected to generate 1.21 times less return on investment than Chengdu Kanghua. But when comparing it to its historical volatility, Peoples Insurance of is 1.63 times less risky than Chengdu Kanghua. It trades about 0.15 of its potential returns per unit of risk. Chengdu Kanghua Biological is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  4,514  in Chengdu Kanghua Biological on September 14, 2024 and sell it today you would earn a total of  1,307  from holding Chengdu Kanghua Biological or generate 28.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Peoples Insurance of  vs.  Chengdu Kanghua Biological

 Performance 
       Timeline  
Peoples Insurance 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Peoples Insurance of are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Peoples Insurance sustained solid returns over the last few months and may actually be approaching a breakup point.
Chengdu Kanghua Biol 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Chengdu Kanghua Biological are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Chengdu Kanghua sustained solid returns over the last few months and may actually be approaching a breakup point.

Peoples Insurance and Chengdu Kanghua Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Peoples Insurance and Chengdu Kanghua

The main advantage of trading using opposite Peoples Insurance and Chengdu Kanghua positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Peoples Insurance position performs unexpectedly, Chengdu Kanghua can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chengdu Kanghua will offset losses from the drop in Chengdu Kanghua's long position.
The idea behind Peoples Insurance of and Chengdu Kanghua Biological pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamental Analysis
View fundamental data based on most recent published financial statements